- Home
- RLAY vs NVEC Comparison
RLAY vs NVEC Comparison
Compare RLAY & NVEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- NVEC
- Stock Information
- Founded
- RLAY 2015
- NVEC 1989
- Country
- RLAY United States
- NVEC United States
- Employees
- RLAY N/A
- NVEC N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- NVEC Semiconductors
- Sector
- RLAY Health Care
- NVEC Technology
- Exchange
- RLAY Nasdaq
- NVEC Nasdaq
- Market Cap
- RLAY 576.1M
- NVEC 359.4M
- IPO Year
- RLAY 2020
- NVEC 1996
- Fundamental
- Price
- RLAY $3.60
- NVEC $75.63
- Analyst Decision
- RLAY Strong Buy
- NVEC
- Analyst Count
- RLAY 11
- NVEC 0
- Target Price
- RLAY $18.40
- NVEC N/A
- AVG Volume (30 Days)
- RLAY 1.5M
- NVEC 86.6K
- Earning Date
- RLAY 08-05-2025
- NVEC 07-21-2025
- Dividend Yield
- RLAY N/A
- NVEC 5.26%
- EPS Growth
- RLAY N/A
- NVEC N/A
- EPS
- RLAY N/A
- NVEC 3.11
- Revenue
- RLAY $7,679,000.00
- NVEC $25,874,694.00
- Revenue This Year
- RLAY $17.59
- NVEC N/A
- Revenue Next Year
- RLAY N/A
- NVEC N/A
- P/E Ratio
- RLAY N/A
- NVEC $24.60
- Revenue Growth
- RLAY N/A
- NVEC N/A
- 52 Week Low
- RLAY $1.78
- NVEC $51.50
- 52 Week High
- RLAY $10.72
- NVEC $89.98
- Technical
- Relative Strength Index (RSI)
- RLAY 57.25
- NVEC 59.06
- Support Level
- RLAY $3.50
- NVEC $74.63
- Resistance Level
- RLAY $3.86
- NVEC $77.23
- Average True Range (ATR)
- RLAY 0.18
- NVEC 2.19
- MACD
- RLAY 0.02
- NVEC 0.12
- Stochastic Oscillator
- RLAY 65.79
- NVEC 81.88
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About NVEC NVE Corporation
NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.